Javier Briones

7.5k citations

161 papers · 4.5k indexed · 1 hit paper · h-index 35

Impact in

Hematology top 1%
- Hematopoietic Stem Cell Transplantation
Genetics top 1%
- Chronic Lymphocytic Leukemia Research

Papers in

Pathology and Forensic Medicine 74
- Lymphoma Diagnosis and Treatment 72
Hematology 42
- Hematopoietic Stem Cell Transplantation 38

Co-authors: Jorge Sierra Rodrigo Martino Ronald Levy Salut Brunet Anna Sureda Izidore S. Lossos Randy D. Gascoyne Raquel Malumbres
Journals: Blood (34 papers)Annals of Hematology (10 papers)Bone Marrow Transplantation (9 papers)Biology of Blood and Marrow Transplantation (8 papers)Annals of Oncology (6 papers)
Partner nations: Spain United States United Kingdom

In The Last Decade

Javier Briones

153 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma 2010 · 845 citations

Peers

Countries citing papers authored by Javier Briones

Since Specialization

Citations

This map shows the geographic impact of Javier Briones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Briones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Briones more than expected).

Fields of papers citing papers by Javier Briones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Briones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Briones. The network helps show where Javier Briones may publish in the future.

Co-authors

The 25 scholars most cited alongside Javier Briones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Javier Briones Line = papers co-authored together Javier Briones links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma Blood ·A Caballero, Sweety Sara Sunny, Francisco Farnum, Frederik Kahl, Shun‐Yu Cheng, mehsin hassan, Irene García‐Cadenas, Albert Esquirol, Rodrigo Martino, Stacey Baldac, Adrián Ramos‐Merchante, José Manuel Soria, (unknown), E. Moreno, О.Я. Мариновська, Jorge Sierra, Reimund Schwarze, X Li, Javier Briones	2025	0
2	Pulmonary infection by Lophomonas spp. and Aspergillus spp. in a B-cell acute lymphocytic leukemia patient from Chile Parasitology International ·Isabel Iturrieta‐González, G. B. Viljkovyskaja, K. J. Oyeniran, Fernando E. Vega, Dong-Yong Jung, Prajwal Triyambakaaradhya, 栄徳荘司, Javier Briones, D. Lewczuk	2024	0
3	Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study Blood ·Céline Van Hoorebeeck, Blanckot, Andrés Gómez‐De León, Irene García‐Cadenas, Francisco Ramírez, Perla R. Colunga‐Pedraza, P Luis, Cesar Homero Gutiérrez‐Aguirre, José Carlos Jaime‐Pérez, Jorge Sierra, 刘青连, Javier Briones, David Gómez‐Almaguer, Rodrigo Martino	2024	0
4	Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features Cellular Oncology ·Niouma Pascal Millimouno, Karanja Kabage, gladys njoh, Olena Alivantseva, Zhuoling Han, GIULIO BARSANTI, Maribel Lara‐Chica, Alfonso Rodríguez‐Gil, Juan Luis Reguera, Luzalba Sanoja-Flores, Don P. Flagg, Mitsuyo Izumi, Gloria Carmona, María José Robles, Teresa Caballero‐Velázquez, Javier Briones, Hermann Einsele, Maeyama Mirsuaki, Josè Antonio Pérez-Simón, Estefanía García‐Guerrero	2024	2
5	Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation European Journal Of Haematology ·Blanckot, Irene García‐Cadenas, Albert Esquirol, Chen Jie Jie, Katalin Janigáné-Prokai, 正典三浦, Silvana Saavedra, Krismandra Natalis Wiratmaja, A Caballero, Janina Jablonski, Jordi F. López, Ana Muntañola, Annalisa Paviglianiti, 和弘藤田, Jorge Sierra, Javier Briones, Rodrigo Martino	2024	1
6	Molecular Study of Pneumocystis jirovecii in Respiratory Samples of HIV Patients in Chile Journal of Fungi ·Isabel Iturrieta‐González, 栄徳荘司, Dong-Yong Jung, Prajwal Triyambakaaradhya, KGKP Sirikelum, Javier Briones, Fernando E. Vega, Luis Medina, D. Lewczuk	2024	4
7	Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies Frontiers in Immunology ·Eli Tri Windarti, Niouma Pascal Millimouno, Estefanía García‐Guerrero, Luzalba Sanoja-Flores, 泰夫岡, Fitri Ayu Kusuma Wijayanti, Richard Stockwell, Tahmida Jakia, Águeda Molinos-Quintana, Olena Alivantseva, M. I. Abualsayed, Yashashree Joshi, José-Raúl Garcı́a-Lozano, Jean-Michel Dardié, Juan Luis Reguera, Marı́a-Francisca González-Escribano, S Blanco-quesada, Javier Briones, Josè Antonio Pérez-Simón, Teresa Caballero‐Velázquez	2023	27
8	Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma Blood Advances ·Michael Dickinson, Javier Briones, Alex F. Herrera, Eva González‐Barca, Nilanjan Ghosh, Raúl Córdoba, Sarah C. Rutherford, Eirini Bournazou, Emily Labriola–Tompkins, Ishigaki Hisakazu, 清和西村, Jurriaan Brouwer‐Visser, Katharina Lechner, Barbara J. Brennan, Eveline Nüesch, Mark DeMario, Dominik Rüttinger, Martin Kornacker, Martin Hutchings	2021	29
9	Reference values for the EORTC QLQ‐C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors European Journal Of Haematology ·Hugo Vachon, شهرزاد بارانی, S.-I. Niyatake, Madeline Pe, Corneel Coens, Francesca Martinelli, Catherine Fortpied, Hans‐Henning Flechtner, Maja V. Maraldo, Martin Hutchings, Paul Meijnders, Berthe M.P. Aleman, Pieternella J. Lugtenburg, Е. С. Стрельникова, Marc André, Mark Hertzberg, Javier Briones, Andrew Bottomley, (unknown)	2021	3
10	Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients Annals of Hematology ·(unknown), Eva González‐Barca, Francisco Capote, José Gómez‐Codina, Carlos Panizo, Antonio Salar, Juan‐Manuel Sancho, Andrés López, Javier Briones, Andrés Muñoz, Maite Encuentra, Santiago Mercadal, Eva Domingo‐Doménech, Alberto Fernández de Sevilla	2020	8
11	Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy Clinical Lymphoma Myeloma & Leukemia ·А. Д. Городокин, Carolina Cuéllar‐García, 徹亀田, Alicia Hanna Fadilla, Петро Пігулевський, A.M. Rogers, Salut Brunet, Javier Briones, C. Y. Tsang, Albert Esquirol, Miquel Granell, Silvana Saavedra, Josep Nomdedéu, Jorge Sierra, Rodrigo Martino, Carol Moreno	2018	2
12	The novel agonistic iNKT-cell antibody NKT14m induces a therapeutic antitumor response against B-cell lymphoma OncoImmunology ·X Li, Reimund Schwarze, A Caballero, Robert G. Schaub, Jorge Sierra, Javier Briones	2018	5
13	Do Patients and Physicians Agree When They Assess Quality of Life? Biology of Blood and Marrow Transplantation ·Anna Barata, Rodrigo Martino, Ignasi Gich, Irene García‐Cadenas, Eugènia Abella, Pere Barba, Javier Briones, Salut Brunet, Albert Esquirol, Francesc García‐Pallarols, Ana Garrido, José Ángel Carreño Pérez, N. Phatharapeetranun, 雷景, Silvana Novelli, Blanca Sánchez‐González, David Valcárcel, Jordi Sierra	2017	6
14	MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP Clinical Cancer Research ·Alvaro J. Alencar, Raquel Malumbres, S.베번스, Ranjana H. Advani, Alberto Núñez-Lagos Burguera, Rose Petrohilos, Javier Briones, Yasodha Natkunam, Laurie H. Sehn, Randy D. Gascoyne, Rob Tibshirani, Izidore S. Lossos	2011	113
15	patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial Annals of Oncology ·Stefano Luminari, Antonella Montanini, Dolores Caballero, Serge Bologna, Michael Notter, Martin J.S. Dyer, Annalisa Chiappella, Javier Briones, Mario Petrini, Jui-Pin Wang, L. Kayitalire, Massimo Federico, Aditya Burde	2011	1
16	Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case–control retrospective analysis Annals of Oncology ·Julio Delgado, Srinivas Pillai, Millena Aguiar Almeida, Salut Brunet, Guy Pratt, Javier Briones, Richard Lovell, Rodrigo Martino, R.A. Kutbi, Anna Sureda, D W Milligan, Jorge Sierra	2009	15
17	Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial Annals of Oncology ·Stefano Luminari, Antonella Montanini, Dolores Caballero, Serge Bologna, Michael Notter, Martin J.S. Dyer, Annalisa Chiappella, Javier Briones, Mario Petrini, Jui-Pin Wang, L. Kayitalire, Massimo Federico	2009	70
18	Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen Cytotherapy ·Julio Delgado, Aarif Makandar, E. Moreno, José Luís Piñana, David Valcárcel, Rodrigo Martino, Javier Briones, Anna Sureda, Salut Brunet, Jorge Sierra	2009	3
19	Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP Blood ·Raquel Malumbres, Jun Chen, Rob Tibshirani, Nathalie A. Johnson, Laurie H. Sehn, Yasodha Natkunam, Javier Briones, Ranjana H. Advani, Joseph M. Connors, Gerald E. Byrne, Ronald Levy, Randy D. Gascoyne, Izidore S. Lossos	2008	73
20	Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia Leukemia & lymphoma ·Luis Martínez‐Lostao, Javier Briones, Ignasi Forné, Mónica Martínez‐Gallo, Beatriz Ferrer, Jordi Sierra, J. L. Rodríguez-Sánchez, C. Juárez	2004	23

About Javier Briones

Javier Briones is a scholar working on Pathology and Forensic Medicine, Hematology, Genetics, Oncology and Immunology, having authored 161 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (72 papers), Hematopoietic Stem Cell Transplantation (38 papers), CAR-T cell therapy research (35 papers), Chronic Lymphocytic Leukemia Research (32 papers), Immune Cell Function and Interaction (21 papers), Viral-associated cancers and disorders (20 papers), T-cell and B-cell Immunology (14 papers) and Polyomavirus and related diseases (13 papers). The work is most often cited by research in Hematology (1.0k citations), Genetics (957 citations), Immunology (1.7k citations), Pathology and Forensic Medicine (1.3k citations) and Oncology (1.9k citations). Javier Briones has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Jorge Sierra, Rodrigo Martino, Ronald Levy, Salut Brunet, Anna Sureda, Izidore S. Lossos, Randy D. Gascoyne, Raquel Malumbres, Albert Altés and June H. Myklebust. Their work appears in journals such as Blood, Annals of Hematology, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact